Established in 2017 in Navi Mumbai, Maharashtra, India, Mediexa Pharma has emerged as a trusted supplier and trader of high-quality pharmaceutical formulations designed to support effective healthcare treatments. We deal in a comprehensive range of products including Erlotinib Tablets IP, Gefitinib Tablets IP, Eltrombopag Tablets, Cyclosporine Capsules IP, and Bortezomib Injection IP. With a strong commitment to therapeutic reliability and quality compliance, we ensure that every product supplied by us meets strict pharmaceutical standards for safety, stability, and effectiveness. Our operational practices are driven by precision-focused quality measures, dependable packaging solutions, and consistent product integrity to meet the evolving demands of the healthcare industry.
Supported by a skilled team, Mediexa Pharma continuously strives to strengthen healthcare accessibility through dependable supply capabilities and customer-focused services. We believe in maintaining long-term professional relationships through ethical business practices, timely delivery, and uncompromised quality standards. The company remains committed to contributing positively to the pharmaceutical sector with reliable healthcare solutions and trusted service excellence.
Key Facts of Mediexa Pharma:
|
Nature
of Business
|
Supplier,
Trader
|
|
Location
|
Navi
Mumbai, Maharashtra, India
|
|
Year
Of Establishment
|
2017
|
|
No.
of Employees
|
06
|
|
GST
Number
|
27ABFFM5974K1ZN
|
|
Modes
of Transport
|
By
Air, Rail, Road
|
|
Modes
of Payment
|
Cheque/DD
|
|
| |
|
|
Send Inquiry
Send Inquiry
